Volunteers to be offered wearable WHOOP Strap 3.0 fitness tracker
Abu Dhabi-based G42 Healthcare has announced a volunteer healthcare management programme with Boston-based wearable technology firm WHOOP.
The partnership will offer volunteers participating in the world’s first Phase III trials of an Covid-19 vaccine the opportunity to benefit from a 24/7 fitness and health monitor to measure key biometrics. This is the first trial of its kind to feature wearable technology and will include thousands of volunteers who are participating in the trials.
The Whoop4Humanity initiative ensures that volunteers can further enhance their volunteer journey by using the new wearable devices which will enable them to check their daily heart rate, respiratory rate, heart rate variability, sleep performance, and more.
“We believe that giving volunteers an opportunity to use the WHOOP Strap 3.0 wearable device will reinforce their confidence in the trial by giving them the ability to check on several daily health data points,” noted Ashish Koshy, CEO, G42 Healthcare.
“WHOOP is proud to partner with G42 Healthcare and participate in their innovative Phase III Covid-19 vaccine trial,” remarked Will Ahmed, WHOOP Founder & CEO.
